BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7128136)

  • 1. Effects of oral contraception on liver function tests and serum proteins in women with past viral hepatitis.
    Shaaban MM; Hammad WA; Fathalla MF; Ghaneimah SA; El-Sharkawy MM; Salim TH; Ali MY; Liao WC; Smith SC
    Contraception; 1982 Jul; 26(1):65-74. PubMed ID: 7128136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oral contraception on liver function tests and serum proteins in women with active schistosomiasis.
    Shaaban MM; Hammad WA; Falthalla MF; Ghaneimah SA; El-Sharkawy MM; Salim TH; Liao WC; Smith SC
    Contraception; 1982 Jul; 26(1):75-82. PubMed ID: 7128137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oral contraception on serum bile acid.
    Shaaban MM; Ghaneimah SA; Mohamed MA; Abdel-Chani S; Mostafa SA
    Int J Gynaecol Obstet; 1984 Apr; 22(2):111-5. PubMed ID: 6145634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver function tests and low-dose estrogen oral contraceptives.
    Dickerson J; Bressler R; Christian CD
    Contraception; 1980 Dec; 22(6):597-603. PubMed ID: 7214908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid and biochemical changes after low-dose oral contraception.
    Loke DF; Ng CS; Holck S; Hall PE; Ratnam SS
    Contraception; 1992 Sep; 46(3):227-41. PubMed ID: 1451519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver function tests in patients on oral progestogens.
    Engineer AD; Gupta V; Tandon P
    J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oral contraceptives on some biochemical aspects in bilharzial Egyptian females living in rural areas.
    Hefnawi FI; Zein-el-abedin A; Saber MA; Abdel RS; Yousry F
    Popul Sci; 1982; (3):63-72. PubMed ID: 12266218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some biochemical effects of long term oral contraceptive therapy on Egyptian females living in rural areas.
    Hefnawi FI; Zein-el-abedin A; Saber MA; Abdel RS; Yousry F
    Popul Sci; 1982; (3):101-12. PubMed ID: 12266211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oral contraceptive on liver function tests of women with schistosomiasis in the Philippines.
    Sy FS; Osteria TS; Opiniano V; Gler S
    Contraception; 1986 Sep; 34(3):283-94. PubMed ID: 3098499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of subdermal levonorgestrel contraceptive implants, Norplant, on liver functions.
    Shaaban MM; Elwan SI; el-Sharkawy MM; Farghaly AS
    Contraception; 1984 Nov; 30(5):407-12. PubMed ID: 6440736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
    Wilson ES; Cruickshank J; McMaster M; Weir RJ
    Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum bile acids during biphasic contraceptive treatment with ethinyl estradiol and norgestrel.
    Heikkinen J; Ylöstalo P; Mäentausta O; Jänne O
    Contraception; 1982 Jan; 25(1):89-95. PubMed ID: 6800694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Liver function and iatrogenic anovulation].
    Ramírez Sánchez J; Rojas L; Anzola F
    Rev Colomb Obstet Ginecol; 1969; 20(1):11-7. PubMed ID: 5402152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contraceptive steroid effects on nonreproductive organ systems.
    Corson SL
    J Reprod Med; 1986 Sep; 31(9 Suppl):865-78. PubMed ID: 3772906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum.
    Kuhnz W; Staks T; Jütting G
    Contraception; 1994 Dec; 50(6):563-79. PubMed ID: 7705098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation.
    Kuhnz W; al-Yacoub G; Fuhrmeister A
    Contraception; 1992 Nov; 46(5):455-69. PubMed ID: 1458892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version.
    Carlborg L
    Contraception; 1983 May; 27(5):439-52. PubMed ID: 6349925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.